Author

Marion Joy

University of PittsburghORCID 0009-0008-9045-7456Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 3 Approach:experimental assay· 3 Organism:human· 3 Assay:bulk RNA-seq· 2 Research Focus:differential expression· 2 Assay:scRNA-seq· 2 Approach:statistical model· 2 Research Focus:cancer & tumor microenvironment· 1

Frequent Co-Authors

Brian Robert IsettiD· 2 shared Jason J. LukeiD· 2 shared Katelyn Smith· 2 shared Peter C. LucasiD· 2 shared Riyue BaoiD· 2 shared Sarah Newman· 2 shared Aatur Dilip SinghiiD· 1 shared Adam C. SoloffiD· 1 shared

Activity by Year

2023-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 34 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Brian Robert IsettORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cancer BiologybioRxivPreprintJun 16, 2026

Integrative multi-omic analysis identifies tumor-intrinsic p38 as a driver of immune exclusion in human epithelial cancers

Rebekah Dadey, Krishna Beer Singh, Rose Doerfler…·Riyue Bao

This study identifies tumor-intrinsic p38 activation as a driver of immune exclusion in epithelial cancers and suggests it as a therapeutic target to overcome immunotherapy resistance.

DOI 10.64898/2026.06.11.731716

humanscRNA-seq

𝕏 PostBluesky

Cell BiologyMolecular Biology of the CellPeer-reviewedAug 28, 2024

mDia2 is an important mediator of MRTF-A-dependent regulation of breast cancer cell migration

Ian Eder, Virginia Yu, Jacob Antonello…·Partha Sarathi Roy

This study identifies mDia2 as a mediator of MRTF-A-dependent breast cancer cell migration and links MRTF activity to malignancy, suggesting it as a therapeutic target.

8 citations

humanproteomics

𝕏 PostBluesky

Cell BiologyJournal for ImmunoTherapy of CancerPeer-reviewedOct 1, 2023

Identification of tumor-intrinsic drivers of immune exclusion in acral melanoma

Ryan C. Augustin, Sarah Newman, Aofei Li…·Riyue Bao

This study identifies 11 oncogenic pathways associated with immune exclusion and ICI resistance in acral melanoma, suggesting therapeutic targets for immunotherapy combinations.

28 citations

humanbulk RNA-seq

𝕏 PostBluesky